Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jan Trøst Jørgensen. (2015) Companion diagnostics: the key to personalized medicine. Expert Review of Molecular Diagnostics 15:2, pages 153-156.
Read now
Read now
Lesley J Burgess & Marli Terblanche. (2011) The future of the pharmaceutical, biological and medical device industry. Open Access Journal of Clinical Trials 3, pages 45-50.
Read now
Read now
Articles from other publishers (18)
Hyun Jee Han, Chinedu Ekweremadu & Nairuti Patel. (2019) Advanced drug delivery system with nanomaterials for personalised medicine to treat breast cancer. Journal of Drug Delivery Science and Technology 52, pages 1051-1060.
Crossref
Crossref
Jan Trøst Jørgensen. (2019) Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy. The Oncologist 24:7, pages e432-e440.
Crossref
Crossref
Michael W. Hoffmann. 2019. Assembly of the Executive Mind. Assembly of the Executive Mind
205
218
.
Jan Trøst Jørgensen & Maria Hersom. 2019. Companion and Complementary Diagnostics. Companion and Complementary Diagnostics
1
10
.
J.T. Jørgensen & K.B. Nielsen. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
530
545
.
Eva Sverrisdóttir, Trine Meldgaard Lund, Anne Estrup Olesen, Asbjørn Mohr Drewes, Lona Louring Christrup & Mads Kreilgaard. (2015) A review of morphine and morphine-6-glucuronide’s pharmacokinetic–pharmacodynamic relationships in experimental and clinical pain. European Journal of Pharmaceutical Sciences 74, pages 45-62.
Crossref
Crossref
Anja Hitz & Lea Prevel Katsanis. (2014) A consumer adoption model for personalized medicine: an exploratory study. International Journal of Pharmaceutical and Healthcare Marketing 8:4, pages 371-391.
Crossref
Crossref
Alexandra S. Potter, Geoffrey Dunbar, Emily Mazzulla, David Hosford & Paul A. Newhouse. (2014) AZD3480, a Novel Nicotinic Receptor Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults. Biological Psychiatry 75:3, pages 207-214.
Crossref
Crossref
T. Bieber & K. Broich. (2013) Personalisierte MedizinPersonalised medicine. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:11, pages 1468-1472.
Crossref
Crossref
Thomas Friedli & Daniel Bellm. 2013. Leading Pharmaceutical Operational Excellence. Leading Pharmaceutical Operational Excellence
77
102
.
Jan Trøst Jørgensen. (2012) Companion Diagnostics and the Drug-Diagnostic Codevelopment Model. Drug Development Research 73:7, pages 390-397.
Crossref
Crossref
Jan Trøst Jørgensen. (2011) A challenging drug development process in the era of personalized medicine. Drug Discovery Today 16:19-20, pages 891-897.
Crossref
Crossref
Elizabeth O Lillie, Bradley Patay, Joel Diamant, Brian Issell, Eric J Topol & Nicholas J Schork. (2011) The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?. Personalized Medicine 8:2, pages 161-173.
Crossref
Crossref
Henrik Winther & Jan Trøst Jørgensen. (2012) Drug-Diagnostic Co-Development in Cancer. Pharmaceutical Medicine 24:6, pages 363-375.
Crossref
Crossref
Jan Jørgensen. 2010. Molecular Diagnostics. Molecular Diagnostics
325
344
.
Richard J. Epstein. (2010) Digitization and Its Discontents: Future Shock in Predictive Oncology. Seminars in Oncology 37:1, pages 60-64.
Crossref
Crossref
Jan Trøst JørgensenHenrik Winther. (2009) The new era of personalized medicine: 10 years later. Personalized Medicine 6:4, pages 423-428.
Crossref
Crossref
Richard J. Epstein. (2009) Unblocking Blockbusters: Using Boolean Text-Mining to Optimise Clinical Trial Design and Timeline for Novel Anticancer Drugs. Cancer Informatics 7, pages CIN.S2666.
Crossref
Crossref